Ndc.Hno

NDC.HNO maintains a strong liquidity position, with a current ratio of 2.56, indicating that the company has more than double the current assets to cover its current liabilities. The company also holds $50 billion in cash and equivalents, which provides a significant buffer against short-term obligations. The absence of long-term debt further enhances its financial flexibility, as the debt-to-equity ratio is 0.0.

In terms of profitability, NDC.HNO demonstrates strong returns, with a return on equity (ROE) of 13.86% and a return on assets (ROA) of 10.99%. These figures are well above the typical thresholds for the pharmaceutical industry, suggesting that the company is efficiently utilizing its equity and asset base to generate profits.

The company's revenue is concentrated in a single business segment, as no segmental breakdown is disclosed in the available data. Geographically, the data does not provide a breakdown of revenue by region, but the absence of long-term debt and high liquidity suggests that the company is not overly exposed to regional financial risks.

NDC.HNO is positioned for continued growth, with a strong operating cash flow of $104.7 billion and free cash flow of $56.8 billion. The capital expenditure of -$27.2 billion indicates a reduction in investment in physical assets, which may reflect a shift toward cost optimization or a mature business model. The company's revenue of $928 billion suggests a large and stable base, which supports a positive outlook for the current and next fiscal years.

The risk assessment for NDC.HNO indicates a low level of liquidity and dilution risk. The company has no immediate filing-based liquidity or dilution flags, and the absence of long-term debt and high cash reserves further supports this assessment. The dilution potential is also low, as the number of basic and diluted shares outstanding is identical, indicating no imminent threat from share issuance.

There are no recent events or filings disclosed in the available data that would suggest a material change in the company's operations or financial position. The company appears to be operating in a stable environment, with no significant regulatory or geopolitical risks highlighted in the data.